Join
Live feed
·
PRReleasevia Quantisnow
Theratechnologies Inc. logo

Theratechnologies June 13 Oncology Investigator Call to Update Investors & Analysts on Phase 1 Sudocetaxel Zendusortide Trial

ByQuantisnow·Wall Street's wire, on your screen.
THTX· Theratechnologies Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track THTX (Theratechnologies Inc.) and more on Quantisnow.